Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Reta is supported by Janoshik third-party testing, with the test report available for researchers, laboratories and procurement buyers to review
Retatrutide dosing schedule Retatrutide dosage in clinical trials A phase 1 clinical trial of retatrutide involved 72 individuals with diagnosed type 2 diabetes who received 12 mg once weekly retatrutide injections subcutaneously for 12 weeks
Candidacy is assessed individually
Use these tools with your clinician for best results
PMID: 191 FanSMengQSahaTSarkarFHRosenEM
The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity: A Systematic Review of Randomized, Controlled Studies
US$ 24.77
US$ 22.52
US$ 25.84
US$ 22.56
